ctrl K

AI Score

Unlock

Intellia Therapeutics Inc... (NTLA)

AI Score

Unlock

6.64

-0.47 (-6.61%)

At close: Apr 01, 2025, 3:59 PM

6.71

0.98%

After-hours: Apr 01, 2025, 07:54 PM EDT

Intellia Therapeutics Income Statement

Chart Mode

Year	FY24	FY23	FY22	FY21	FY20
Revenue	57.88M	36.27M	52.12M	33.05M	57.99M
Cost of Revenue	n/a	8.98M	7.57M	6.89M	150.41M
Gross Profit	57.88M	27.3M	44.55M	26.16M	-92.41M
Operating Income	-534.26M	-515.29M	-458.16M	-267.85M	-136.58M
Interest Income	47.81M	49.83M	8.54M	1.28M	2.35M
Pretax Income	-519.02M	-481.19M	-474.19M	-267.89M	-134.23M
Net Income	-519.02M	-481.19M	-490.21M	-259.72M	-125.57M
Selling & General & Admin	125.83M	116.5M	90.31M	71.1M	44.17M
Research & Development	466.31M	435.07M	419.98M	229.81M	150.41M
Other Expenses	n/a	n/a	n/a	n/a	n/a
Operating Expenses	592.14M	551.57M	510.29M	300.9M	194.58M
Interest Expense	n/a	n/a	8.54M	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	592.14M	551.57M	510.29M	300.9M	194.58M
Income Tax	n/a	n/a	16.02M	-8.17M	-8.66M
Shares Outstanding (Basic)	98.85M	88.77M	76.97M	70.89M	55.99M
Shares Outstanding (Diluted)	98.85M	88.77M	76.97M	70.89M	55.99M
EPS (Basic)	-5.25	-5.42	-6.37	-3.66	-2.24
EPS (Diluted)	n/a	n/a	n/a	n/a	n/a
EBITDA	-523.98M	-506.31M	-450.59M	-260.96M	-130.27M
Depreciation & Amortization	10.29M	8.98M	7.57M	6.89M	6.31M